doctors are worried about prescribing glp 1 GLP-1s great, but researchers are busy looking to add options for patients. A new U-M study reveals a missing step in a weight control pathway that could be targeted for obesity Why You Need To Work

Exploring the impact of sodium-glucose cotransporter-2 inhibitors on genitourinary toxicities in prostate cancer patients undergoing radiation therapy: a case study and discussion

Roche Holding AG Sanofi S.A

In fact, the omitted study was a pooled analysis of 5 RCTs 196,197,198,199,200 of 5,325 patients with obesity followed for up to 3 years, which had shown that liraglutide was no different from placebo for depressive symptoms as scored on the Patient Health Questionnaire-9, while also highlighting a small increased risk of suicidal behavior 193

The new figure reflects trends influencing how these drugs are priced, how long patients stay on them, and how patient populations are segmented, says Asad Haider, head of the healthcare business unit within Goldman Sachs Research

PlexusDx emphasizes that the predictability of your dosing schedulesame day, same time each weekmaximizes the medication's ability to reshape your appetite neurobiology

Slow down how quickly food leaves your stomach, helping you feel full longer